Skip to main content
Signal8

Faga Daniel

SEC insider (Form 3/4/5 filer). CIK 0001673528. President, CEO at First Tracks Biotherapeutics, Inc. (TRAX) and 1 other issuer. 56 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2026. Located in SAN DIEGO, CA.

Companies Faga Daniel has filed insider reports for

  • First Tracks Biotherapeutics, Inc. (TRAX): Director, Officer, President, CEO
  • ANAPTYSBIO, INC (ANAB): Director, Officer, President, CEO
Faga Daniel profile photo

Faga Daniel

CIK: 0001673528

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (23.2%)

Position reduction

Option Exercises (M)5 (8.9%)

Derivative conversions

Awards (A)28 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)10 (17.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

First Tracks Biotherapeutics, Inc. logo
TRAX

First Tracks Biotherapeutics, Inc.

DirectorOfficer
ANAPTYSBIO, INC logo
ANAB

ANAPTYSBIO, INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (56 total)

  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Aug 15, 2026
    Award

    Performance Stock Units

    Direct
    193.6K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Aug 2, 2026
    Award

    Performance Stock Units

    Direct
    193.6K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Restricted Stock Unit

    Direct
    100.2K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    271.1K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    11K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    194.9K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    194.9K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    379.6K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    2.3K shares-
  • ANAPTYSBIO, INC logo
    ANAB

    ANAPTYSBIO, INC

    Apr 20, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    9.2K shares-

1-10 of 56

…